1. Home
  2. OCUL vs PGNY Comparison

OCUL vs PGNY Comparison

Compare OCUL & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • PGNY
  • Stock Information
  • Founded
  • OCUL 2006
  • PGNY 2008
  • Country
  • OCUL United States
  • PGNY United States
  • Employees
  • OCUL N/A
  • PGNY N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • PGNY Misc Health and Biotechnology Services
  • Sector
  • OCUL Health Care
  • PGNY Health Care
  • Exchange
  • OCUL Nasdaq
  • PGNY Nasdaq
  • Market Cap
  • OCUL 1.8B
  • PGNY 2.0B
  • IPO Year
  • OCUL 2014
  • PGNY 2019
  • Fundamental
  • Price
  • OCUL $11.92
  • PGNY $22.49
  • Analyst Decision
  • OCUL Strong Buy
  • PGNY Buy
  • Analyst Count
  • OCUL 7
  • PGNY 8
  • Target Price
  • OCUL $17.33
  • PGNY $24.00
  • AVG Volume (30 Days)
  • OCUL 2.0M
  • PGNY 1.0M
  • Earning Date
  • OCUL 08-05-2025
  • PGNY 08-07-2025
  • Dividend Yield
  • OCUL N/A
  • PGNY N/A
  • EPS Growth
  • OCUL N/A
  • PGNY N/A
  • EPS
  • OCUL N/A
  • PGNY 0.57
  • Revenue
  • OCUL $59,647,000.00
  • PGNY $1,213,181,000.00
  • Revenue This Year
  • OCUL N/A
  • PGNY $7.61
  • Revenue Next Year
  • OCUL $20.85
  • PGNY $11.39
  • P/E Ratio
  • OCUL N/A
  • PGNY $39.66
  • Revenue Growth
  • OCUL N/A
  • PGNY 9.46
  • 52 Week Low
  • OCUL $5.79
  • PGNY $13.39
  • 52 Week High
  • OCUL $12.35
  • PGNY $28.36
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 68.93
  • PGNY 47.81
  • Support Level
  • OCUL $11.76
  • PGNY $22.82
  • Resistance Level
  • OCUL $12.35
  • PGNY $23.81
  • Average True Range (ATR)
  • OCUL 0.45
  • PGNY 0.72
  • MACD
  • OCUL -0.07
  • PGNY -0.06
  • Stochastic Oscillator
  • OCUL 69.93
  • PGNY 33.33

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About PGNY Progyny Inc.

Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.

Share on Social Networks: